Evaluation of atezolizumab immunogenicity: Efficacy and safety (Part 2)

• Main Authors: Solange Peters (Author), Peter R. Galle (Author), Coen A. Bernaards (Author), Marcus Ballinger (Author), René Bruno (Author), Valerie Quarmby (Author), Jane Ruppel (Author), Alexandr Vilimovskij (Author), Benjamin Wu (Author), Nitzan Sternheim (Author), Martin Reck (Author)
• Format: Book
• Published: Wiley, 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Antibody therapeutics can be associated with unwanted immune responses resulting in the development of anti‐drug antibodies (ADA). Optimal methods to evaluate the potential effects of ADA on clinical outcomes in oncology are not well established. In this study, we assessed efficacy and safe...